Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Experimental Pathology|January 1, 1988
Histochemical changes in the composition of mucins in goblet cells during methotrexate-induced mucosal atrophy in ratsJ F Koninkx, A F Stemerdink, M H Mirck, et al.Pediatric Pulmonology|September 1, 1995
Biochemical lung maturity, static respiratory compliance, and pulmonary gas transfer in intubated preterm infants with and without respiratory distress syndromeJ P de Winter, J Egberts, I T Merth, et al.Oncogene|June 6, 2006
TRAIL promotes metastasis of human pancreatic ductal adenocarcinomaA Trauzold, D Siegmund, B Schniewind, et al.The Cochrane Database of Systematic Reviews|August 4, 2018
Diagnostic tests for autism spectrum disorder (ASD) in preschool childrenMelinda Randall, Kristine J Egberts, Aarti Samtani, et al.Pediatrics|December 1, 1993
Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trialJ Egberts, J P de Winter, G Sedin, et al.American Journal of Respiratory Cell and Molecular Biology|October 1, 1990
Fetal mouse alveolar type II cells in culture express several type II cell characteristics found in vivo, together with major histocompatibility antigensL C Oomen, A A Ten Have-Opbroek, P C Hageman, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 17, 2021
Mast Cell Distribution in Human Carotid Atherosclerotic Plaque Differs Significantly by Histological SegmentJoost M Mekke, Daan H J Egberts, Farahnaz Waissi, et al.European Journal of Cancer (Oxford, England : 1990)|January 18, 2011
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerF A Castro, A Försti, S Buch, et al.Nature Communications|August 18, 2017
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme BM Wroblewski, R Bauer, M Cubas Córdova, et al.Breast (Edinburgh, Scotland)|December 6, 2007
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trialP Kenemans, E Kubista, J M Foidart, et al.Pageof 8